BIO-TECHNE Corp Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax
BIO-TECHNE Corp (TECH) had Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax of -$12.30 million as of 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Accumulated Other Comprehensive Income (Loss), Net of Tax
us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax · last filed 2014-05-12
- 2014-03-31: Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax -$12.30M.
- 2013-12-31: Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax -$13.04M.
- 2013-09-30: Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax -$16.38M.
- 2013-06-30: Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax -$24.28M.
| Period end | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax |
|---|---|
| 2014-03-31 | -$12.30M 10-Q · filed 2014-05-12 |
| 2013-12-31 | -$13.04M 10-Q · filed 2014-02-04 |
| 2013-09-30 | -$16.38M 10-Q · filed 2013-11-12 |
| 2013-06-30 | -$24.28M 10-Q · filed 2014-05-12 |
| 2013-03-31 | -$24.98M 10-Q · filed 2013-05-10 |
| 2012-12-31 | -$15.71M 10-Q · filed 2013-02-11 |
| 2012-09-30 | -$16.82M 10-Q · filed 2012-11-09 |
| 2012-06-30 | -$20.74M 10-K · filed 2013-08-29 |
| 2012-03-31 | -$17.65M 10-Q · filed 2012-05-10 |
| 2011-12-31 | -$21.55M 10-Q · filed 2012-02-07 |
| 2011-09-30 | -$20.84M 10-Q · filed 2011-11-09 |
| 2011-06-30 | -$16.94M 10-K · filed 2013-08-29 |
| 2010-06-30 | -$21.97M 10-K · filed 2012-08-29 |
| 2009-06-30 | -$8.04M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |